Emerging evidence is highlighting a critical need for routine liver risk stratification in individuals living with obesity. According to a new study reported this week, such systematic assessment is essential for the early detection and management of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).
The findings reflect a growing consensus that the global crisis of MASLD requires a more proactive, risk-based clinical strategy. Identifying high-risk individuals earlier could facilitate timely medical interventions before liver damage becomes irreversible.
The Link Between Obesity and Liver Disease
Obesity has become a primary driver of inflammation and the accumulation of liver fat. It is currently the most rapidly growing indication for liver transplantation on a global scale.
Researchers emphasize that obesity-related MASLD requires dedicated risk stratification because of its significant clinical associations. These include:
- Increased risk of liver failure
- Higher incidence of hepatocellular carcinoma (HCC)
- Elevated risk of cardiovascular complications
Because MASLD often remains asymptomatic in its early stages, many patients are only diagnosed once they have reached advanced stages of the disease. At that point, the damage to the liver may already be permanent.
Why Risk Stratification is Essential
Current management of MASLD has largely focused on lifestyle interventions and metabolic control. However, the study authors argue that a risk-based strategy should now become a standard component of clinical care.
They suggest that routine assessment of liver risk in people with obesity would allow clinicians to prioritize therapeutic decisions and surveillance. This approach would mirror how cardiovascular risk is currently stratified in primary care settings.
Effective routine risk stratification involves a combination of several factors:
- Evaluation of clinical risk factors such as waist circumference
- Assessment of insulin resistance and dyslipidaemia
- Use of non-invasive tests to check for liver fat and fibrosis
These assessments allow healthcare providers to identify patients with early or advanced disease, ensuring they receive targeted follow-up or necessary referral to hepatology services.
Impact on Hepatology and Healthcare Systems
Integrating liver risk assessment into routine practice for patients with obesity, diabetes, or metabolic syndrome could significantly reduce the long-term burden on healthcare systems. By promoting earlier lifestyle changes and therapeutic measures, clinicians can potentially prevent the progression to more severe, costly disease states.
While these recommendations have not yet been formalized into official clinical guidelines, the emphasis on systematic stratification reflects an evolving understanding of the disease. The researchers conclude that early detection is critical for managing the rising rates of MASLD-related complications.
